Latest Gaming News

Stealth Group Holdings has reported its strongest financial year yet, with record sales and profits, while announcing a major acquisition that promises to reshape its market footprint.

Biotron Limited’s lead HBV drug BIT-HBV001 demonstrates superior antiviral activity and synergy with the current standard treatment Tenofovir in preclinical models, advancing hopes for a more effective Hepatitis B therapy.

Streamplay Studio Limited’s subsidiary Noodlecake Studios has launched Winter Burrow globally on Xbox, Nintendo Switch, and Steam, backed by strong pre-launch demand and significant platform funding.

Activeport Group has landed a major contract to provide orchestration software for a GPU platform in Thailand, marking a significant step into the country’s expanding $10 billion telecommunications market.

Light & Wonder, Inc. transitions from an ASX Foreign Exempt Listing to a full ASX Listing, marking a significant regulatory shift without raising new capital. The company continues trading its shares as CHESS Depositary Interests on a 1, 1 basis.

Aristocrat Leisure reported robust FY25 results with 11% revenue growth to A$6.3 billion and a 12% rise in NPATA, fueled by strong performances across its gaming segments and strategic acquisitions. The company signals continued profit growth in FY26, underpinned by organic expansion and market share gains.

Aristocrat Leisure has delivered a robust FY25 performance with double-digit growth in earnings and revenue, underpinned by market share gains and strategic portfolio realignment. The company also returned $1.4 billion to shareholders through dividends and buy-backs.

Aristocrat Leisure reported robust FY25 results with revenue up 11% to $6.3 billion and a 12% rise in normalised net profit after tax before amortisation. The company boosted dividends by 19% and completed key acquisitions and divestitures, positioning itself for future growth.

Light & Wonder, Inc. is set to extend its substantial share repurchase program to include its ASX-listed CHESS Depositary Interests starting November 7, 2025, coinciding with its planned Nasdaq delisting.

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

Light & Wonder, Inc. reported a 3% revenue increase for Q3 2025, driven by its Gaming and iGaming segments, alongside completing the Grover acquisition and refinancing debt with $1 billion in senior notes.

Light & Wonder, Inc. posted robust Q3 2025 results, driven by strong gaming operations and record iGaming revenue, while advancing its transition to a sole ASX listing.